English | 中文

Absea is an antibody company established in 2001. We provide custom antibody services and antibody reagents world-wide for academic and industrial research purposes. Our major customers are from European countries and the North America. We have set up the ISO9001 quality management system since 2009.

The Board and Management:

Wei Zhang PhD is Chairman and Managing Director of Absea. Dr Zhang received PhD from Cambridge University and worked as a research associate at the Molecular Immunopathology Unit, MRC Centre in Cambridge before coming back to China. Dr Zhang is also a senior research scientist at the Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.

Frank Grosveld PhDFRS, is a Professor of Cell Biology and Genetics, Erasmus MC, Rotterdam, The Netherlands. He has been awarded the Louis-Jeantet Prize (1991) and the Spinoza Prize (1995) for his scientific contributions to the field of gene expression and is a founding board member of Harbour Antibodies BV.

Tao Chen is experienced in method development and industrial translation. He made contributions to the HCAB antibody platform of Harbour Antibodies BV and the broadly used gene editing assessment algorithm TIDE while he was studying in the Netherlands. Now he is the CEO of Unogen Biological Science Ltd., developing novel protein engieering technologies.

       © 2011 Absea Biotechnology Ltd. All rights reserved. Power by:010BEST  京ICP备11007005号  京公网安备110108003924号